Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
16.24
+0.24 (1.50%)
At close: Dec 5, 2025, 4:00 PM EST
16.06
-0.18 (-1.11%)
After-hours: Dec 5, 2025, 7:55 PM EST
RGC Market Cap
RGC has a market cap or net worth of $8.03 billion as of December 5, 2025. Its market cap has increased by 9,423.47% in one year.
Market Cap
8.03B
Enterprise Value
8.03B
1-Year Change
9,423.47%
Ranking
Category
Stock Price
$16.24
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $8.03B, an increase of 6,586.51%. That is a compound annual growth rate of 160.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.03B | 12,392.31% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.63M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |